ClariTrial | Search Clinical Trials

Explore/HIV Infections

Status

Phase

11,832 results for “HIV Infections”

Page 1 of 789

Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Phase 3HIV Infections

Abacavir sulfate, Lamivudine and ZidovudineAtazanavirLamivudine/Zidovudine+7 more

National Institute of Allergy and Infectious Diseases (NIAID)1,125 participants60 sites · United States, Puerto Rico

Compare CT.gov Full analysis →

Completed

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

Phase 4Staphylococcus AureusHIV Infections

Mupirocin calcium ointment, 2%Placebo ointment

Columbia University100 participants2 sites · United StatesCompletes Apr 2006

Compare CT.gov Full analysis →

Completed

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Phase 1HIV InfectionsHIV Seronegativity

ALVAC(2)120(B,MN)GNP (vCP1452)

National Institute of Allergy and Infectious Diseases (NIAID)110 participants13 sites · United States

Compare CT.gov Full analysis →

UNKNOWN

iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care

N/AHIV

Conditional economic incentive

University of Cape Town87 participants1 site · South AfricaCompletes Jul 2016

Compare CT.gov Full analysis →

Completed

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Phase 1HIV Infections

Peptides on autologous Dendritic Cells

Statens Serum Institut12 participants1 site · DenmarkCompletes Apr 2008

Compare CT.gov Full analysis →

Completed

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

N/ACandidiasis, OralHIV Infections

Terbinafine hydrochloride

Novartis30 participants9 sites · United States

Compare CT.gov Full analysis →

Completed

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

N/AHIVContraception

HEC Placebo GelPlacebo Vaginal InsertPlacebo Vaginal Film+1 more

CONRAD422 participants2 sites · South Africa, ZimbabweCompletes Jun 2017

Compare CT.gov Full analysis →

Completed

Results posted

Testing Integrative Smoking Cessation for HIV Patients

Phase 4SmokingSmoking CessationHIV Infections

Nicotine Replacement TherapyMindfulness Training Smoking Cessation InterventionContingency Management Smoking Cessation Intervention

University of Miami95 participants1 site · United StatesCompletes May 2024

Compare CT.gov Full analysis →

Recruiting

Enhanced Problem-solving Therapy and HIV Engagement Support to Improve Perinatal Mental Health & HIV Outcomes in Malawi

N/AHIVDepressionDepression, Postpartum

Enhanced Friendship BenchEnhanced usual care

University of North Carolina, Chapel Hill400 participants5 sites · MalawiCompletes Jun 2028

Compare CT.gov Full analysis →

Completed

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

N/AHIV Infection

National Institute of Allergy and Infectious Diseases (NIAID)240 participants1 site · United States

Compare CT.gov Full analysis →

Completed

Marijuana for HIV-Related Peripheral Neuropathy

Phase 1Phase 2Peripheral Nervous System DiseasesHIV Infections

Smoked Marijuana

Center for Medicinal Cannabis Research50 participants1 site · United States

Compare CT.gov Full analysis →

Not Yet Recruiting

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

N/AHIV SeropositivityHIV Drug ResistanceHIV Infections

ANRS, Emerging Infectious Diseases30,060 participantsCompletes Sep 2036

Compare CT.gov Full analysis →

Completed

Results posted

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

N/AHIVDepression

Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management AlgorithmEnhanced Standard of Care

International Maternal Pediatric Adolescent AIDS Clinical Trials Group156 participants13 sites · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

A Multicenter, Double-Blind, Phase III, Adjuvant-Controlled Study of the Effect of 10 Units of HIV-1 Immunogen (Remune) Compared to Incomplete Freund's Adjuvant (IFA) Alone Every 12 Weeks on AIDS-Free Survival in Subjects With HIV Infection and CD4 T-Lymphocytes Between 300 and 549 Cells/microL Rega

Phase 3HIV Infections

HIV-1 Immunogen

The Immune Response Corporation3,000 participants54 sites · United States

Compare CT.gov Full analysis →

Completed

Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections

N/AChlamydia InfectionsGonorrhea

Nucleic acid amplification test

Centers for Disease Control and Prevention3,900 participants1 site · United StatesCompletes Jan 2006

Compare CT.gov Full analysis →

1–15 of 11,832

Explore/HIV Infections

Status

Phase

11,832 results for “HIV Infections”

Page 1 of 789

Completed

Comparison of Three Different Initial Treatments Without Protease Inhibitors for HIV Infection

Phase 3HIV Infections

Abacavir sulfate, Lamivudine and ZidovudineAtazanavirLamivudine/Zidovudine+7 more

National Institute of Allergy and Infectious Diseases (NIAID)1,125 participants60 sites · United States, Puerto Rico

Compare CT.gov Full analysis →

Completed

Mupirocin Ointment to Eliminate Nasal Carriage of Staphylococcus Aureus in HIV Infection

Phase 4Staphylococcus AureusHIV Infections

Mupirocin calcium ointment, 2%Placebo ointment

Columbia University100 participants2 sites · United StatesCompletes Apr 2006

Compare CT.gov Full analysis →

Completed

Safety and Immune Response Study of High-Dose Canarypox ALVAC-HIV Vaccine in Healthy, HIV Uninfected Adults

Phase 1HIV InfectionsHIV Seronegativity

ALVAC(2)120(B,MN)GNP (vCP1452)

National Institute of Allergy and Infectious Diseases (NIAID)110 participants13 sites · United States

Compare CT.gov Full analysis →

UNKNOWN

iLink (Incentives for Linkage to ART) Study: A Mixed-methods Study to Improve Linkage to HIV Care

N/AHIV

Conditional economic incentive

University of Cape Town87 participants1 site · South AfricaCompletes Jul 2016

Compare CT.gov Full analysis →

Completed

Vaccination With Autologous Dendritic Cells Pulsed With HIV-Antigens for Treatment of Patients With Chronic HIV-Infection

Phase 1HIV Infections

Peptides on autologous Dendritic Cells

Statens Serum Institut12 participants1 site · DenmarkCompletes Apr 2008

Compare CT.gov Full analysis →

Completed

Safety and Effectiveness of Giving Lamisil to HIV-Positive Subjects With Thrush Who Have Not Responded to Fluconazole Treatment

N/ACandidiasis, OralHIV Infections

Terbinafine hydrochloride

Novartis30 participants9 sites · United States

Compare CT.gov Full analysis →

Completed

The Quatro Study: Acceptability Study of (Placebo) Vaginal Delivery Forms for Preventing HIV and Unintended Pregnancy

N/AHIVContraception

HEC Placebo GelPlacebo Vaginal InsertPlacebo Vaginal Film+1 more

CONRAD422 participants2 sites · South Africa, ZimbabweCompletes Jun 2017

Compare CT.gov Full analysis →

Completed

Results posted

Testing Integrative Smoking Cessation for HIV Patients

Phase 4SmokingSmoking CessationHIV Infections

Nicotine Replacement TherapyMindfulness Training Smoking Cessation InterventionContingency Management Smoking Cessation Intervention

University of Miami95 participants1 site · United StatesCompletes May 2024

Compare CT.gov Full analysis →

Recruiting

Enhanced Problem-solving Therapy and HIV Engagement Support to Improve Perinatal Mental Health & HIV Outcomes in Malawi

N/AHIVDepressionDepression, Postpartum

Enhanced Friendship BenchEnhanced usual care

University of North Carolina, Chapel Hill400 participants5 sites · MalawiCompletes Jun 2028

Compare CT.gov Full analysis →

Completed

Influenza Vaccine in HIV Infection: Immune Response and Effect on Viral Load

N/AHIV Infection

National Institute of Allergy and Infectious Diseases (NIAID)240 participants1 site · United States

Compare CT.gov Full analysis →

Completed

Marijuana for HIV-Related Peripheral Neuropathy

Phase 1Phase 2Peripheral Nervous System DiseasesHIV Infections

Smoked Marijuana

Center for Medicinal Cannabis Research50 participants1 site · United States

Compare CT.gov Full analysis →

Not Yet Recruiting

Study of the Prevalence of Transmitted HIV-1 Resistance, Viral Diversity, and Cluster Identification in Patients at the Time of HIV-1 Diagnosis

N/AHIV SeropositivityHIV Drug ResistanceHIV Infections

ANRS, Emerging Infectious Diseases30,060 participantsCompletes Sep 2036

Compare CT.gov Full analysis →

Completed

Results posted

IMPAACT 2002: Cognitive Behavioral Therapy and Medication Management for Treatment of Depression in US Youth With HIV

N/AHIVDepression

Health and Wellness Combined Cognitive Behavioral Therapy and a Medication Management AlgorithmEnhanced Standard of Care

International Maternal Pediatric Adolescent AIDS Clinical Trials Group156 participants13 sites · United StatesCompletes Sep 2019

Compare CT.gov Full analysis →

Completed

Phase 3HIV Infections

HIV-1 Immunogen

The Immune Response Corporation3,000 participants54 sites · United States

Compare CT.gov Full analysis →

Completed

Nucleic Acid Amplification Tests (NAATs) for the Diagnosis of Pharyngeal and Rectal Chlamydia and Gonorrhea Infections

N/AChlamydia InfectionsGonorrhea

Nucleic acid amplification test

Centers for Disease Control and Prevention3,900 participants1 site · United StatesCompletes Jan 2006

Compare CT.gov Full analysis →

1–15 of 11,832